IQE PLC
16 January 2008
16 January 2008
IQE plc
Appointment of Joint Broker
The Directors of IQE plc (the 'Company' or 'IQE') are pleased to announce with
immediate effect the appointment of Panmure Gordon (UK) Limited as joint broker
to the Company alongside Noble & Company Limited, who remain as nominated
adviser (NOMAD) and joint brokers.
Dr Drew Nelson, President and Chief Executive of IQE, commented:
'We are delighted to appoint Panmure Gordon as joint broker. We look forward to
benefiting from the experience and expertise in the UK and US institutional
markets of Panmure Gordon and their US business ThinkPanmure, and to increased
exposure for IQE on both sides of the Atlantic.'
For further information, please contact:
IQE plc +44 (0)29 2083 9400
Dr Drew Nelson, CEO
Phil Rasmussen, CFO
Panmure Gordon (UK) Limited +44 (0)20 7459 3600
Aubrey Powell
Andrew Collins
Noble & Company Limited +44 (0)20 7763 2200
John Llewellyn-Lloyd
Sam Reynolds
College Hill Associates + 44 (0) 207 457 2020
Adrian Duffield
Ben Way
About IQE plc
IQE is the leading global supplier of advanced semiconductor wafers with
products that cover a diverse range of applications, supported by an innovative
outsourced foundry services portfolio that allows the Group to provide a 'one
stop shop' for the wafer needs of the world's leading semiconductor
manufacturers.
IQE uses advanced crystal growth technology (epitaxy) to manufacture and supply
bespoke semiconductor wafers ('epi-wafers') to the major chip manufacturing
companies, who then use these wafers to make the chips which form the key
components of virtually all high technology systems. IQE is unique in being able
to supply wafers using all of the leading crystal growth technology platforms.
IQE's products are found in many leading-edge consumer, communication, computing
and industrial applications, including a complete range of wafer products for
the wireless industry, such as mobile handsets and wireless infrastructure,
Wi-Fi, WiMAX, base stations, GPS, and satellite communications; optical
communications, optical storage (CD, DVD), laser optical mouse, laser printers &
photocopiers, thermal imagers, leading-edge medical products, barcode, high
efficiency LEDs and a variety of advanced silicon based systems.
The manufacturers of these chips are increasingly seeking to outsource wafer
production to specialist foundries such as IQE in order to reduce overall wafer
costs and accelerate time to market.
IQE also provides bespoke R&D services to deliver customized materials for
specific applications and offers specialist technical staff to manufacture to
specification either at its own facilities or on the customer's own sites. The
Group is also able to leverage its global purchasing volumes to reduce the cost
of raw materials. In this way IQE's outsourced services, provide compelling
benefits in terms of flexibility and predictability of cost, thereby
significantly reducing operating risk.
IQE operates six manufacturing facilities located in Cardiff (two) and Milton
Keynes in the UK; in Bethlehem, Pennsylvania and Somerset, New Jersey in the
USA; and Singapore. The Group also has 11 sales offices located in major
economic centres worldwide.
###
This information is provided by RNS
The company news service from the London Stock Exchange PPFQLFFVFBBBBD
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.